(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 4.81% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.58%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.34%.
Albemarle's revenue in 2025 is $4,946,415,000.On average, 27 Wall Street analysts forecast ALB's revenue for 2025 to be $600,963,639,240, with the lowest ALB revenue forecast at $574,246,297,660, and the highest ALB revenue forecast at $640,627,710,220. On average, 27 Wall Street analysts forecast ALB's revenue for 2026 to be $608,731,676,880, with the lowest ALB revenue forecast at $454,430,201,940, and the highest ALB revenue forecast at $755,853,601,880.
In 2027, ALB is forecast to generate $684,764,287,720 in revenue, with the lowest revenue forecast at $529,756,627,540 and the highest revenue forecast at $946,288,221,600.